Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
McCord et al., 2020
Sourcing Quality Peptides in Canada For Canadian researchers and users, obtaining legitimate, high-quality peptides requires understanding the landscape and identifying reliable sources
The newly formed cysteinylglycine S -conjugates are further processed by dipeptidases/aminopeptidases to remove the glycyl group and produce cysteine S -conjugates
Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges
Novartis Pluvicto established radioligand therapy as a commercial reality (2022+): Lutetium-177 PSMA-617 (Pluvicto) for metastatic castration-resistant prostate cancer achieved rapid adoption post-2022 launch, validating the peptide receptor radionuclide therapy platform and creating a template for multiple follow-on radioligand therapy programmes
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
